Sampre Nutritions Ltd
Sampre Nutritions Ltd (SAMPRE) last traded at ₹5.77, a market capitalisation of ₹54.8 crore, on a P/E of 15.4. Over the past 52 weeks the stock has ranged between ₹4.51 and ₹42.3. Sampre Nutritions Ltd last reported results for the quarter ended Jun 2026, with sales of ₹14.85 crore and net profit of ₹0.7 crore. Sampre Nutritions Ltd’s annual general meeting is scheduled for 4 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Sampre Nutritions Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Sampre Nutritions Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹14.85 cr, up 36.6% from ₹10.87 cr a year earlier. Net profit was ₹0.7 cr, down 1.4% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 7.27 | 5.58 | 7.77 | 10.87 | 10 | 7.39 | 15.1 | 14.85 |
| Expenses | 6.26 | 5.14 | 14.04 | 9.49 | 8.06 | 5.91 | 14.67 | 13.35 |
| Operating profit | 1.01 | 0.44 | -6.27 | 1.38 | 1.94 | 1.48 | 0.43 | 1.5 |
| OPM % | 13.89% | 7.89% | -80.69% | 12.70% | 19.40% | 20.03% | 2.85% | 10.10% |
| Other income | 0 | 0.04 | 0.31 | 0.03 | 0.01 | 0 | 0.67 | 0.07 |
| Interest | 0.45 | 0.59 | 0.58 | 0.31 | 0.28 | 0.26 | 0.51 | 0.26 |
| Depreciation | 0.44 | 0.44 | 0.66 | 0.39 | 0.61 | 0.5 | 0.54 | 0.51 |
| Profit before tax | 0.12 | -0.55 | -7.2 | 0.71 | 1.06 | 0.72 | 0.05 | 0.8 |
| Tax % | 0.00% | 0.00% | 2.08% | 0.00% | 16.04% | 13.89% | -2,600.00% | 12.50% |
| Net profit | 0.12 | -0.54 | -7.35 | 0.71 | 0.9 | 0.62 | 1.35 | 0.7 |
| EPS (₹) | 0.03 | -0.08 | -0.88 | 0.08 | 0.10 | 0.07 | 0.14 | 0.07 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Sampre Nutritions Ltd annual results
| ₹ crore | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| Sales | 37.11 | 25.15 | 25.12 | 43.35 | 47.34 |
| Operating profit | 4.06 | 4.12 | -3.85 | 4.78 | 5.35 |
| OPM % | 10.94% | 16.38% | -15.33% | 11.03% | 11.30% |
| Net profit | 0.35 | 0.23 | -7.67 | 3.08 | 3.57 |
| EPS (₹) | 0.13 | 0.08 | -0.91 | 0.32 | 0.38 |
TTM is the trailing twelve months to the most recent quarter.
Sampre Nutritions Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 5%
- TTM
- 50%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 106%
- TTM
- 151%
- 10 Years
- -7%
- 5 Years
- 9%
- 3 Years
- -25%
- 1 Year
- -69%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- -2%
- Last Year
- 3%
Sampre Nutritions Ltd shareholding pattern
Promoters held 14.04% at Jun 2026, up from 12.11% at Jun 2025. FIIs 0.00%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 28.36% | 14.16% | 14.16% | 12.11% | 12.11% | 15.26% | 14.04% | 14.04% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.43% | 0.00% |
| Public | 71.63% | 85.83% | 85.85% | 87.89% | 87.89% | 84.75% | 85.54% | 85.96% |
| No. of shareholders | 4,586 | 5,346 | 5,359 | 5,301 | 6,538 | 8,890 | 8,560 | 8,947 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Sampre Nutritions Ltd’s AGM?
Sampre Nutritions Ltd’s annual general meeting is scheduled for 4 Sept 2026.
- AGM35th Annual General Meeting
See the full results calendar for every Indian company reporting in the next 30 days.
Sampre Nutritions Ltd corporate filings
- The company has dispatched the letter to all the shareholders holding shares of the company in physical form, containing a QR code that provides direct access to the Annual Report available ....AGM/EGMlow impact
Cruxal's analysis: Sampre Nutritions Limited has issued a formal notice regarding its 35th Annual General…
Read the full analysis - This is a corrigendum to the Notice of the 35th AGM. There was a typographical error in the date of appointment of the scrutinizer. The said error has been rectified. Neither any material ....AGM/EGMmedium impact
Cruxal's analysis: Sampre Nutritions Limited has scheduled its 35th Annual General Meeting for 04 September…
Read the full analysis - Newspaper advertisement for the Notice of 35th AGM sent to the members of the Company to be held on Friday, 04 September 2026, at 11:00 A.M. (IST).Company Updatelow impact
Cruxal's analysis: Sampre Nutritions Limited has issued an intimation regarding the publication of its 35th…
Read the full analysis - Annual report of the company for the financial year 2025-26. The intimation for the annual report and the notice of the 35th AGM together has been intimated on 10 August 2026.Othersmedium impact
Cruxal's analysis: Sampre Nutritions Limited has scheduled its 35th Annual General Meeting for 04 September…
Read the full analysis - Notice of the 35th AGM of the Company to be held on Friday, 04 September 2026, at 11:00 A.M. (IST), through video conferencing ("VC") / other audio-visual means ("OAVM") along with the ....AGM/EGMmedium impact
Cruxal's analysis: Sampre Nutritions Limited has issued a notice for its 35th Annual General Meeting…
Read the full analysis - Newspaper publication of the unaudited standalone and consolidated financial results of the company for the first quarter ended 30 June 2026 for the financial year 2026-27.Company Updatelow impact
Cruxal's analysis: Sampre Nutritions Limited has released its unaudited standalone and consolidated…
Read the full analysis - (i) In compliance with Regulation 33 of the SEBI (LODR) Regulations, 2015, the unaudited standalone and consolidated financial results along with the limited review report, is attached ....Board Meetingmedium impact
Cruxal's analysis: Sampre Nutritions Limited reported Q1 FY27 standalone revenue from operations of 14.85…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Sampre Nutritions Ltd
Cruxal reads every Sampre Nutritions Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.